Antibody development

At InVivo BioTech Services, we now offer rapid antibody development workflows as a fully integrated service. Using your antigens, we initiate the development process with the immunization of rabbits, mice, or other species, followed by the isolation and selection of high‑performing B cells.

A key advantage of our platform is the first functional testing of antibody‑producing cells directly on the Bruker Beacon microchip system. Our technology significantly accelerates development timelines, increases the number of viable antibody candidates, and enables deeper functional insights at an earlier stage.

Once top candidates are identified, we deliver antibody sequences. InVivo can immediately proceed with small‑scale production of newly discovered antibodies, enabling rapid progression into research, validation, or preclinical development.

InVivo Biotech is your partner for rapid antibody discovery. We identify and screen antibodies for our customers from a wide range of species, including human, mouse, rabbit, alpaca, and others. This approach enables the generation of highly diverse antibody candidates, even against challenging targets such as multi-transmembrane proteins and difficult-to-access epitopes. From initial rapid antibody discovery through functional validation and bioreactor-based manufacturing, InVivo delivers a high-quality solution that accelerates your path from concept to product. Image provided courtesy of Bruker Spatial Biology, Inc..

Picture source LINK: https://brukercellularanalysis.com/applications/antibody-discovery/